Manufacturing defect leads to temporary halt of rabies vaccine production

04/29/2010 | SmallAnimalChannel.com

Merial recently announced that it has temporarily stopped releasing IMRAB rabies vaccines, after discovering a defect in a small number of vials. The problem doesn't affect doses on the market, a spokeswoman said. "Merial is working cooperatively with the USDA to remedy the issues and return to full supply as soon as possible," the Duluth, Ga., company said.

View Full Article in:

SmallAnimalChannel.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ